XML 18 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Compensation Plans (Tables)
9 Months Ended
Sep. 30, 2019
Share-Based Compensation Plans  
Schedule of Company's stock option activity

The following table summarizes the Company’s stock option activity for the nine-month period ended September 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

 

Exercise

 

Contractual

 

Intrinsic

 

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2018

 

1,173,620

 

$

26.57

 

  

 

 

  

Granted

 

192,650

 

$

23.45

 

  

 

 

  

Exercised

 

(18,795)

 

$

27.75

 

  

 

 

  

Forfeited or expired

 

(2,850)

 

$

31.80

 

  

 

 

  

Outstanding at September 30, 2019

 

1,344,625

 

$

27.31

 

4.4

 

$

 —

Exercisable at September 30, 2019

 

866,830

 

$

27.05

 

2.2

 

$

 —


*     The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of the Company’s stock on September 30, 2019 ($22.61)  and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.As of September 30, 2019, there were no in-the-money stock options outstanding, therefore the aggregate intrinsic value was zero.

Schedule of Company's stock option exercise activity

The following table summarizes the Company’s stock option exercise activity for the three and nine months ended September 30, 2019 and 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

    

2019

    

2018

    

2019

    

2018

 

 

(Dollars in thousands)

Total intrinsic value of stock options exercised

 

$

 —

 

$

654

 

$

88

 

$

3,704

Net proceeds from stock option exercises

 

$

 —

 

$

260

 

$

161

 

$

4,308

Income tax benefit from the exercise of stock options

 

$

 —

 

$

170

 

$

23

 

$

963

 

Schedule of Company's restricted stock award

The following table summarizes the Company’s restricted stock award activity for the nine-month period ended September 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

Shares of

 

Average

 

Remaining

 

Aggregate

 

 

Restricted

 

Grant Date

 

Contractual

 

Intrinsic

 

    

Stock

    

Fair Value

    

Term (Years)

    

Value*

Non-vested at December 31, 2018

 

61,480

 

$

30.74

 

  

 

 

  

Issued

 

31,000

 

 

23.48

 

  

 

 

  

Vested

 

(23,745)

 

 

24.63

 

  

 

 

  

Non-vested at September 30, 2019

 

68,735

 

$

28.04

 

3.0

 

$

1,554,000


*     The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of the Company’s stock on September 30, 2019 ($22.61) multiplied by the number of non-vested restricted shares outstanding.